A 19 month old Indian girl with tyrosinaemia developed a severe generalised neuropathy involving both phrenic nerves. Treatment with haemarginate failed to improve her condition. After liver transplantation the raised concentrations of the neurotoxin delta aminolaevulinic acid returned to normal and gradual but complete neurological recovery occurred over a period of 13 months. (Arch Dis Child 1994; 70: 544-545) Hereditary tyrosinaemia is a recessive disorder of amino acid metabolism caused by deficiency of fumarylacetoacetate hydrolase. The accumulation of tyrosine metabolites is thought to be the cause of the characteristic acute and/or chronic liver failure, renal tubular defects, and the high risk of eventual formation of hepatocellular carcinoma. Episodes of acute neuropathy, which clinically resemble porphyric crises, occur in up to 40%1 of affected children and may be so severe that mechanical ventilation for respiratory failure is necessary. Although most children who survive regain normal neurological function between crises, the mortality is high (up to 65%).
Case report A girl of 19 months with tyrosinaemia was referred with paralysis involving respiratory muscles and all four limbs. The diagnosis had been made at the age of 6 months and she was treated with an appropriate diet and made good developmental progress. However, she had become unwell one month before her admission with progressive weakness and breathlessness which lead to respiratory failure within two weeks. Electrophysiological studies demonstrated a severe demyelinating neuropathy affecting her arms more than her legs; brain stem studies were normal. She also had a renal tubular acidosis, was hypertensive and had greatly raised concentrations of a fetoprotein (820 kUMl, normal value less than 10) but no evidence of hepatoma on magnetic resonance imaging. She was given a 14 day course of haemarginate (Normosang, Medica Pharmaceutical Company) which may benefit the neurological problem by inhibiting the formation of the neurotoxins delta aminolaevulinic acid (ALA) and porphobilinogen (PBG).2 As there was no clinical improvement it was decided that liver transplantation offered the only realistic hope of recovery. One previous report had recorded a successful outcome in a child with similar but less severe symptoms.2
She received an orthotopic graft of a whole donor organ on 18 January 1992 and had normal liver function from 10 days postoperatively. The explanted liver showed typical nodular cirrhosis with dysplastic changes but no tumour formation. The preoperatively increased ALA concentrations returned to normal two days after the operation and remained low (table). Neurological recovery was slow but progressive. With the help of a tracheostomy she was weaned from ventilation after seven weeks, began to talk and crawl after three months, and walked with a slight footdrop by five months. The tracheostomy was removed at seven months. Recovery of full power in all muscle groups had occurred by 13 months. Because of severe cyclosporin induced hypertrichosis she was changed to immunosuppression with FK506 (Fujisawa, Munich) and remains well nearly two years after transplantation with normal hepatic and renal function and normal nerve conduction studies. Episodes in which placebo was given necessitated intravenous or oral analgesics for a mean of 71-3 hours; those in which methylprednisolone was used necessitated it for a mean of 41-3 hours (p=003). When seven patients who developed the sickle cell chest syndrome were excluded from the analysis the difference was more significant (62-5 v 31-0 hours, p=0-0 1). There is a suggestion that patients given methylprednisolone may be more likely to have further painful crises soon after discharge. Five patients were readmitted because of pain within eight days and of those four had been given methylprednisolone.
Discussion
Clearly more studies are needed. High dose methylprednisolone may have a useful role but the possibility of rebound crises is worrying. 
